Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1992-4-10
pubmed:abstractText
To determine the frequency of gastrointestinal toxicity due to intravenous (IV) erythromycin and to attempt to decrease this toxicity by prolonging the infusion time of erythromycin and/or pretreating with the peripheral anticholinergic, glycopyrrolate 0.1 mg IV.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0002-9343
pubmed:author
pubmed:issnType
Print
pubmed:volume
92
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
249-53
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:1546723-Adolescent, pubmed-meshheading:1546723-Adult, pubmed-meshheading:1546723-Age Factors, pubmed-meshheading:1546723-Aged, pubmed-meshheading:1546723-Aged, 80 and over, pubmed-meshheading:1546723-California, pubmed-meshheading:1546723-Erythromycin, pubmed-meshheading:1546723-Female, pubmed-meshheading:1546723-Glycopyrrolate, pubmed-meshheading:1546723-Hospitals, Military, pubmed-meshheading:1546723-Humans, pubmed-meshheading:1546723-Incidence, pubmed-meshheading:1546723-Infusions, Intravenous, pubmed-meshheading:1546723-Male, pubmed-meshheading:1546723-Middle Aged, pubmed-meshheading:1546723-Nausea, pubmed-meshheading:1546723-Premedication, pubmed-meshheading:1546723-Questionnaires, pubmed-meshheading:1546723-Severity of Illness Index, pubmed-meshheading:1546723-Time Factors, pubmed-meshheading:1546723-Vomiting
pubmed:year
1992
pubmed:articleTitle
Gastrointestinal side effects of intravenous erythromycin: incidence and reduction with prolonged infusion time and glycopyrrolate pretreatment.
pubmed:affiliation
Department of Internal Medicine, Naval Hospital, San Diego, California 92134-5000.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, Non-P.H.S., Randomized Controlled Trial